CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
Interview +2 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04276935
NCT04276935N/ACompleted
CompareCT.gov

Development of a Health-Related Symptom Index for Spanish-Speaking Persons Diagnosed With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions (HSIL)

AIDS Malignancy Consortium·observational·Posted Feb 19, 2020·Updated Mar 7, 2025

In Brief

An observational study evaluating Interview, Quality-of-Life Assessment, and 1 other intervention for High Grade Anal Canal Squamous Intraepithelial Neoplasia and Human Immunodeficiency Virus. Completed, enrolled 20 participants across 4 sites.

Detailed Summary

This trial develops a health-related symptom index for participants with and either treated or monitored for anal high-grade squamous intraepithelial lesions. The health-related quality of life index may help to capture the symptoms and related experiences of living with or being treated for high-grade squamous intraepithelial lesions.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHigh Grade Anal Canal Squamous Intraepithelial Neoplasia, Human Immunodeficiency Virus
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI), Memorial Sloan Kettering Cancer Center, The Emmes Company, LLC

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedFeb 19, 2020
Enrollment StartNov 6, 2018
Primary CompletionMar 1, 2020
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 6.4 years ago

Interventions

Interviewother

Participate in cognitive interview

Quality-of-Life Assessmentother

Ancillary studies

Questionnaire Administrationother

Ancillary studies